
Boyds records growth following investment strategy
Global drug development consultancy Boyds has reported strong financial growth following a two-year strategy to expand its business. Boyds saw an increase of over 20% year-on-year in annual revenue in the wake of increased demand for drug development expertise across the UK, US, and Europe. … Read More







